相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
Thomas Bachelot et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hormonal Resistance in Breast Cancer: Evolving Treatment Strategies
Mustafa Khasraw et al.
CURRENT BREAST CANCER REPORTS (2012)
Optimizing Endocrine Therapy for Metastatic Breast Cancer
Elizabeth M. Gaughan et al.
CURRENT BREAST CANCER REPORTS (2012)
PI3K pathway inhibitors approach junction
David Holmes
NATURE REVIEWS DRUG DISCOVERY (2011)
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer
Cesar G. Sanchez et al.
BREAST CANCER RESEARCH (2011)
mTOR/S6K1 and MAPK/RSK signaling pathways coordinately regulate estrogen receptor a serine 167 phosphorylation
Rachel L. Yamnik et al.
FEBS LETTERS (2010)
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
Brinda Ravikumar et al.
PHYSIOLOGICAL REVIEWS (2010)
Targeting the phosphoinositide 3-kinase pathway in cancer
Pixu Liu et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody Trastuzumab
Alejandro Vazquez-Martin et al.
PLOS ONE (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance
Julia S. Samaddar et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The roles of therapy-induced autophagy and necrosis in cancer treatment
Ravi K. Amaravadi et al.
CLINICAL CANCER RESEARCH (2007)
Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells
Wei Yue et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer
A Boulay et al.
CLINICAL CANCER RESEARCH (2005)
Aromatase inhibitors: Combinations with fulvestrant or signal transduction inhibitors as a strategy to overcome endocrine resistance
SRD Johnston et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy
RI Nicholson et al.
ENDOCRINE-RELATED CANCER (2004)
Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer
J Shou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer
CK Osborne et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
分享论文
